ASCO: Has AstraZeneca finally found a place for long-plagued I-O candidate tremelimumab? chelfand Sun, 05/31/2020 – 16:58 More: ASCO: Has AstraZeneca finally found a place for long-plagued I-O candidate tremelimumab? Source: fierce
read moreASCO: Merck, Eisai pad case for liver cancer nod with Keytruda-Lenvima combo data chelfand Sun, 05/31/2020 – 14:03 More: ASCO: Merck, Eisai pad case for liver cancer nod with Keytruda-Lenvima combo data Source: fierce
read morePfizer’s Ibrance misses shot at big new market with early breast cancer failure chelfand Sat, 05/30/2020 – 17:46 More: Pfizer's Ibrance misses shot at big new market with early breast cancer failure Source: fierce
read moreRoche’s Tecentriq gets a green light to challenge Bayer with first-in-class liver cancer nod chelfand Fri, 05/29/2020 – 15:30 More: Roche's Tecentriq gets a green light to challenge Bayer with first-in-class liver cancer nod Source: fierce
read moreAbbVie scores ‘game-changer’ nod for Oriahnn in uterine fibroids chelfand Fri, 05/29/2020 – 14:57 More: AbbVie scores 'game-changer' nod for Oriahnn in uterine fibroids Source: fierce
read moreSanofi loses vaccines chief Loew to Ipsen amid global attention on its COVID-19 project aliu Fri, 05/29/2020 – 09:40 More: Sanofi loses vaccines chief Loew to Ipsen amid global attention on its COVID-19 project Source: fierce
read more© 1994 - 2024 B.M. Pharmaceuticals